(Chemo)Radiotherapy-Immunotherapy Combinations: Time to Get Tailored?

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)

Chemoradiotherapy is considered an immunogenic anticancer treatment. Data obtained during the course of chemoradiotherapy treatment of patients with cervical cancer show heterogeneous changes in the tumor immune landscape, highlighting the need for patient selection to rationally design successful combined immunotherapies. Blood-based biomarkers could be valuable to perform such stratification.See related article by Chen et al., p. 3990.

Keyphrases

locally advanced
rectal cancer
early stage
radiation therapy
combination therapy
case report
big data
smoking cessation
deep learning